RxDoctor Payments Data

Michael Dominello, DO

Radiation Oncology · Detroit, MINPI 1003135500

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,443 of the $1,683 with a category attached, or 85.7%. Astrazeneca UK Limited accounts for 86.1% of it on its own, with 2 other manufacturers making up the rest.

$1,683in general payments, 2019–2025

Across 11 payments — averaging $153.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$1K
  • AstraZeneca$202
  • Elekta Instrument AB$32
$96,327in research payments, 2019–2025

Across 51 payments — averaging $1888.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure Inc.$96K
  • AbbVie$706

What the payments were for

  • Travel & lodging$1,44386%
  • Food & beverage$19712%
  • Education$433%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited8$1,449
AstraZeneca2$202
Elekta Instrument AB1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,683 in reported general payments places this provider in the 75th percentile of 198 radiation oncology providers in Michigan.

See all radiation oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$53,040
Medicare patients
108
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →